VGXI and Geneos Therapeutics Expand Partnership for Personalized...

Texas-based GMP Plasmid CDMO VGXI, Inc. and Geneos Therapeutics, Inc. Expand their Clinical Manufacturing Supply Agreement in Support of Geneos’ Ongoing GT-30 Phase Ib/IIa Clinical Trial for advanced...(PRWeb March 16, 2021)Read the full story at https://www.prweb.com/releases/vgxi_and_geneos_therapeutics_expand_partnership_for_personalized_cancer_immunotherapies/prweb17798258.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news